Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Essentials for optimizing outcomes in oncoplastic breast reconstruction.

Gland surgery·2026
Same author

Sensory Outcomes and Neurotization Techniques Following Mastectomies: A Comprehensive Systematic Review.

Cancers·2026
Same author

Rethinking Dangling: Omission of Inpatient Dangle Protocols Shortens Hospital Stay Without Adverse Effects on Lower Extremity Flap Outcomes.

Journal of reconstructive microsurgery·2025
Same author

Antibiotics and Surgical Site Infection in Expander-Based Breast Reconstruction Trial (ASSERT).

Annals of surgical oncology·2025
Same author

Intraoperative Indocyanine Green Angiography Use for Perfusion Assessment in Immediate Breast Reconstruction Is Associated With Reduced Reoperation and Takeback.

The Journal of surgical research·2025
Same author

What Rankings, Ratings, and Utilities Do Breast Cancer Patients Place on Tissue- and Implant-based Breast Reconstruction?

Plastic and reconstructive surgery. Global open·2025

相关实验视频

Updated: May 7, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

2.3K

一个单一机构立即淋巴重建的经验:保险覆盖对降低风险的影响

Anne Huang1, Emma Koesters1, Rebecca M Garza2

  • 1Section of Plastic and Reconstructive Surgery, University of Chicago Medicine & Biological Sciences, Chicago, Illinois, USA.

Journal of surgical oncology
|December 30, 2024
PubMed
概括

即时淋巴重建 (ILR) 的获取受到保险差异的限制,影响乳腺癌患者. 财务障碍可以防止指示的ILR,可能会恶化淋巴的结果.

关键词:
淋巴细胞 淋巴细胞是指淋巴细胞.与乳腺癌相关的淋巴胀.立即进行淋巴重建.淋巴静脉绕道 (Lymphovenous Bypass) 是一种淋巴静脉绕道.

更多相关视频

A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

5.5K
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.4K

相关实验视频

Last Updated: May 7, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

2.3K
A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

5.5K
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.4K

科学领域:

  • 在瘤学瘤学.
  • 手术瘤学手术瘤学
  • 淋巴 edem 研究 研究 淋巴 edem 研究

背景情况:

  • 立即淋巴重建 (ILR) 是一种预防乳腺癌相关淋巴的程序.
  • 在美国,对ILR的保险覆盖是不一致的.
  • 临床下淋巴结参与的患者是ILR的候选人.

研究的目的:

  • 评估保险覆盖和财务资源对获得ILR的影响.
  • 评估ILR在预防淋巴的结果.
  • 识别ILR获取和结果中的差异.

主要方法:

  • 一个潜在的ILR候选人数据库 (2018-2022) 的回顾性审查.
  • 对患者人口统计,保险类型和淋巴发育的分析.
  • 对接受ILR的患者之间的结局进行比较,在指示时没有接受ILR,并且没有对ILR的指示.

主要成果:

  • 在180名ILR候选人中,有50人接受了该程序.
  • 不接受ILR的患者更有可能是黑人,有医疗补助,收入较低.
  • 财务原因占了55%的未执行指示ILR的案件.
  • 淋巴的发病率为14.6% (ILR),12.5% (没有指示) 和40% (指示但未执行).

结论:

  • 保险覆盖和财务资源的差异对ILR的获取产生了负面影响.
  • 缺乏获得指示ILR的机会与更高的淋巴瘤发病率有关.
  • 解决财务障碍对于公平预防乳腺癌患者淋巴结胀至关重要.